India's first indigenously developed vaccine against cervical cancer to be launched tomorrow

India's first indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer is set to be launched on September 1 (Thursday). 

According to official sources, the vaccine will be launched by the Serum Institute of India (SII) and the Department of Biotechnology (DBT). 

The event will be honoured by Union Minister of State (Independent Charge) Science & Technology Jitendra Singh. 

According to Dr NK Arora, Chairperson of the COVID working group, National Technical Advisory Group on Immunisation (NTAGI), it is an exciting experience to launch a made-in-India vaccine.

"It is very exciting and I must say it makes us very happy that our daughters and granddaughters will now be able to get this much-awaited vaccine."

"In fact, this is one of the last major vaccines to be introduced. In fact, this is one of the last vaccines that will be launched in the programme. Now, Indian vaccines will be available and we hope that it will be launched in the National Immunisation programme for 9-14-year-old girls," he added.